Sensus Healthcare to Present at the 20th Annual B. Riley FBR Investor Conference

BOCA RATON, Fla., May 15, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today that Joe Sardano, CEO of the Company, will present a corporate overview at the 20th Annual B. Riley FBR Investor Conference on Thursday, May 23 […]

Cancer Near Eye Treated by SRT

Dr. Kevin Schewe, radiation oncologist and medical director at Alliance Cancer Care Colorado, utilized Sensus Healthcare’s SRT to treat an elderly patient with stage 1 basal cell carcinoma cancer near the eye. Without the help of the SRT, this would have possibly caused the patient immobility of the eyelid. Check out the amazing results! To […]

NBC 9News Features Sensus Healthcare’s SRT

05/10/2019 Watch as Dr. Kevin Schewe, radiation oncologist and medical director at Alliance Cancer Care Colorado, speaks about Sensus Healthcare’s SRT and the amazing effects it has on treating non-melanoma skin cancer. “There are 5.4 million new basal cell and squamous cell skin cancers per year in the United States, developing in 3.3 million people”, […]

Sensus Healthcare Reports First Quarter 2019 Financial Results

– Premier, Inc. adds SRT to its group purchasing contracts – Ships second Sculptura™ system to Rabin Medical Center in Israel – Reaffirms expectations for double-digit full-year revenue growth – Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., May 9, 2019 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company […]

Sensus Healthcare Awarded Brachytherapy Products Agreement with Premier

BOCA RATON, Fla., May 8, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in novel radiation oncology technologies and solutions, has been awarded a group purchasing agreement for Brachytherapy Products with Premier. Effective August 1, 2019, the new agreement allows Premier members, at their discretion, to take advantage of special pricing […]